The Role of FLT3-ITD Mutation on de Novo MDS in Chinese Population

Add time:07/22/2019    Source:sciencedirect.com

BackgroundFLT3 mutations have been well-studied in acute myeloid leukemia (AML), and the detection of the FLT3 gene has become a clinical routine. However, it has not been fully analyzed in other hematologic malignancies, such as myelodysplastic syndromes (MDS).

We also recommend Trading Suppliers and Manufacturers of MDS 004 (cas 103946-64-1). Pls Click Website Link as below: cas 103946-64-1 suppliers

Prev:A phase 2 trial of the oral smoothened inhibitor glasdegib in refractory myelodysplastic syndromes (MDS)
Next:Results of allogeneic stem cell transplantation in the Spanish MDS registry: Prognostic factors for low risk patients)